SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Biotech Bay
Study Shows Rituximab Effective In Treating Chronic Graft-Versus-Host Disease
March 24, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Centient Consulting Inc. Forecast Drives Biotech Higher
March 17, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Rituxan From Genentech, Inc. And Biogen Idec, Inc. (Massachusetts) Approved For Arthritis
March 1, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Genentech, Inc. Suspends Avastin Trial Temporarily
February 13, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Genentech, Inc. Back On Offense
January 17, 2006
 · 
1 min read
Business
Profit Soars At Biotech Giant
January 11, 2006
 · 
1 min read
Drug Development
Breast Cancer Drug Herceptin Looks More Promising
December 9, 2005
 · 
1 min read
Biotech Bay
Nothing Like A Room Full Of Brainiacs To Make A Columnist Feel Small
November 21, 2005
 · 
1 min read
Biotech Beach
The Day In Review: More Good Data For Lucentis From Genentech
November 8, 2005
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Press Releases
Genentech Announces Positive Phase II Results for Petrelintide, an Amylin Analog Developed for People Living With Overweight and Obesity
March 5, 2026
 · 
6 min read
Press Releases
Genentech’s Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1)
March 2, 2026
 · 
14 min read
Press Releases
Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 25, 2026
 · 
22 min read
Press Releases
Genprex Strengthens Intellectual Property Portfolio with Japanese and EU Patents for Reqorsa® Gene Therapy in Combination with Immunotherapies to Treat Cancer
February 23, 2026
 · 
7 min read
Press Releases
FDA Approves Genentech’s Venclexta® Plus Acalabrutinib Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia
February 20, 2026
 · 
17 min read
Press Releases
FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
February 20, 2026
 · 
8 min read
Press Releases
U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
February 20, 2026
 · 
13 min read
Press Releases
FDA accepts New Drug Application for Roche’s giredestrant in ESR1-mutated, ER-positive advanced breast cancer
February 20, 2026
 · 
13 min read
Press Releases
Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease
February 16, 2026
 · 
12 min read
Press Releases
Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)
February 9, 2026
 · 
17 min read
Load More